A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition

Biochemistry
F HamyT Klimkait

Abstract

The main transcriptional regulator of the human immunodeficiency virus, the Tat protein, recognizes and binds to a small structured RNA element at the 5' end of every viral mRNA, termed TAR. On the basis of published structural data of the molecular interactions between TAR and Tat-related peptides, we defined requirements for potential low-molecular weight inhibitors of TAR recognition by the Tat protein. In accordance with the resulting concept, a series of compounds was synthesized. In vitro evaluation of their potential to directly interfere with Tat-TAR interaction was used to define a new chemical class of potent Tat antagonistic substances. The most active compound competed with Tat-TAR complexation with a competition dose CD50 of 22 nM in vitro and blocked HIV expression in a cellular Tat transactivation system with an IC50 of 1.2 microM. The close relation between structural features of the interaction between TAR and a new type of inhibitory agent, "In-PRiNts" (for inhibitor of protein-ribonucleotide sequences), such as CGP 40336A and those of the Tat-TAR complex was confirmed by RNase A footprinting and by two-dimensional NMR. Structural implications for the complex between this class of compounds and TAR RNA will be...Continue Reading

References

Jul 3, 1992·Science·J D PuglisiJ R Williamson
May 1, 1991·Journal of Cellular Biochemistry·B G FeuersteinL J Marton
Jan 1, 1980·Cancer Chemotherapy and Pharmacology·M F BrañaA Jiménez
Sep 15, 1996·European Journal of Biochemistry·S M Kingsman, A J Kingsman

❮ Previous
Next ❯

Citations

Jun 16, 2009·Neurotoxicity Research·Wenxue LiAvindra Nath
Apr 21, 2004·Journal of Molecular Biology·Alastair I H MurchieJonathan Karn
Feb 5, 2003·Advanced Drug Delivery Reviews·Ching-Hsuan Tung, Ralph Weissleder
Oct 15, 2003·Biophysical Chemistry·Nardos Tassew, Michael Thompson
Feb 27, 1999·Current Opinion in Biotechnology·M AfsharG Varani
Aug 10, 2001·Current Opinion in Structural Biology·A C ChengA D Frankel
Sep 25, 2002·Bioorganic & Medicinal Chemistry Letters·Alicia Y Gayle, Anne M Baranger
Jul 31, 1999·Bioorganic & Medicinal Chemistry·N GelusC Bailly
Dec 5, 2000·Current Opinion in Chemical Biology·S J Sucheck, C H Wong
Oct 21, 2009·Journal of Medicinal Chemistry·Yang LiuMichael S Wolfe
Oct 24, 2006·Chemical Communications : Chem Comm·Ziwei XiaoIrving H Goldberg
Apr 15, 2003·Antisense & Nucleic Acid Drug Development·Tomoko Hamma, Paul S Miller
Mar 24, 2011·Future Medicinal Chemistry·Oriana TabarriniVioletta Cecchetti
Nov 11, 1999·Proceedings of the National Academy of Sciences of the United States of America·S HwangT M Rana
Nov 15, 2013·Journal of Virology·Irene GuendelFatah Kashanchi
Jun 29, 2006·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Joy L MorganF Richard Keene
Apr 6, 2004·FEBS Letters·Hong ZhaoLong Jiang
Jul 26, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jianqing PengXiangbo Li
Jun 19, 2004·Journal of Drug Targeting·Rohtash KumarJerry Pelletier
May 24, 2011·Pharmacological Reports : PR·Grzegorz CholewińskiAleksander M Kołodziejczyk
Dec 22, 2007·European Journal of Medicinal Chemistry·Florent BarbaultLihe Zhang
Apr 28, 2007·Journal of Inorganic Biochemistry·Clifford S RossiterJanet R Morrow
May 11, 2005·Chembiochem : a European Journal of Chemical Biology·Steffen RennerGisbert Schneider
Aug 20, 2003·Biopolymers·Coby B CarlsonPeter A Beal
Oct 3, 2003·Chembiochem : a European Journal of Chemical Biology·Andreas KrebsMichael W Göbel
Sep 25, 2007·Chembiochem : a European Journal of Chemical Biology·Verena LudwigMichael W Göbel
Jan 29, 2011·Chemistry : a European Journal·Paula López-SenínVicente Marchán
Aug 8, 2014·ChemMedChem·Aurélie BlondLaurent Micouin
Dec 21, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Li DingMing Yang
Oct 27, 2004·Bioorganic & Medicinal Chemistry Letters·Zhaohui Yan, Anne M Baranger
Jan 13, 2006·Biochemical Pharmacology·Nieves MárquezEduardo Muñoz
Aug 18, 2012·Advances in Virology·Luna LiBrian Wigdahl
Mar 19, 2014·Bioorganic & Medicinal Chemistry·Bert Willis, Dev P Arya
Aug 16, 2006·Bioorganic & Medicinal Chemistry·Longhu ZhouPaul F Torrence
Aug 2, 2003·Chemistry & Biology·Coby B CarlsonPeter A Beal
Sep 12, 2000·Chemistry & Biology·F HamyT Klimkait

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.